China Universal Asset Management Co., Ltd. Eq Rx, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$1.66 - $2.31 $10,167 - $14,148	6,125 Added 95.88%	12,513 $27,000
Q3 2023 Oct 30, 2023	BUY	$1.66 - $2.31 $10,167 - $14,148	6,125 Added 95.88%	12,513 $28,000
Q2 2023 May 21, 2024	SELL	$1.61 - $1.96 $373 - $454	-232 Reduced 3.5%	6,388 $11,000
Q2 2023 Jul 27, 2023	SELL	$1.61 - $1.96 $373 - $454	-232 Reduced 3.5%	6,388 $12,000
Q1 2023 May 21, 2024	BUY	$1.8 - $2.83 $2,984 - $4,692	1,658 Added 33.41%	6,620 $12,000
Q1 2023 Apr 27, 2023	BUY	$1.8 - $2.83 $2,984 - $4,692	1,658 Added 33.41%	6,620 $13,000
Q4 2022 May 21, 2024	BUY	$2.05 - $5.5 $10,172 - $27,291	4,962 New	4,962 $12,000
Q4 2022 Jan 31, 2023	BUY	$2.05 - $5.5 $10,172 - $27,291	4,962 New	4,962 $12,000

Others Institutions Holding EQRX

# of Institutions

Shares Held

67.8M

Call Options Held

Put Options Held

Ah Equity Partners Bio Iii, L.L.C. Menlo Park, CA

19.2M
Shares

$0
100.0% of portfolio
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA

17.4M
Shares

$0
60.15% of portfolio
Arboretum Ventures, Inc.

13.9M
Shares

$0
63.96% of portfolio
Ah Equity Partners Lsv I, L.L.C. Menlo Park, CA

11.4M
Shares

$0
8.42% of portfolio
Ah Equity Partners Lsv Ii, L.L.C. Menlo Park, CA

5M
Shares

$0
11.61% of portfolio

View Full List

About EQRx, Inc.

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

More about EQRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account